The Board of Directors of the Saudi Food and Drug Authority (SFDA) held its 34th meeting, chaired by His Excellency the Chairman of the Board of Directors, Eng. Fahad bin Abdulrahman Al-Jalajel, on Sunday, September 25, 2022.

The Board reviewed a number of items on the agenda and issued a number of decisions regarding them. The Board also reviewed the results of the Authority’s performance in the initiatives of the Kingdom’s Vision 2030 programs for the second quarter of 2022, and the Authority’s performance report in the third strategy for the second quarter of this year.

The Board also discussed the workflow of the fourth strategy formulation project 2023-2027, the Authority's draft budget for the fiscal year 1445/44 AH (2023), and a classification schedule for violations of the provisions of the cosmetic products system.